Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Drug-Linker Conjugates for ADC
    (2)
  • Microtubule Associated
    (2)
  • Antibody-Drug Conjugates (ADCs)
    (1)
  • Apoptosis
    (1)
  • CCR
    (1)
  • PROTAC Linker
    (1)
TargetMol | Tags By Application
  • ELISA
    (1)
  • FACS
    (1)
  • Functional assay
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
Filter
Search Result
Results for "

mcmmae

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
  • PROTAC Products
    1
    TargetMol | PROTAC
  • ADC/ADC Related
    3
    TargetMol | All_Pathways
Mc-MMAE
Maleimidocaproyl-monomethylauristatin E
T18312863971-24-8
Mc-MMAE (Maleimidocaproyl-monomethylauristatin E) is a drug-linker conjugate for ADC. Mc-MMAE is a maleimidocaproyl-conjugated monomethyl auristatin E, which is a potent tubulin inhibitor.
  • $48
In Stock
Size
QTY
TargetMol | Citations Cited
Cys-mc-MMAE
T87843
Cys-mc-MMAE, a Drug-Linker Conjugate for ADC, comprises Monomethyl auristatin E coupled with a linker. It is utilized in the synthesis of ADCs [1].
  • Inquiry Price
Inquiry
Size
QTY
Anti-CCL2 (Carlumab)-VcMMAE
T9901A-1035
Anti-CCL2 (Carlumab)-VcMMAE is an antibody-drug conjugate (ADC) composed of the human-derived anti-CCL2 antibody Carlumab, linked with valine-citrulline (vc) and tubulin inhibitor MMAE. The toxic moiety and linker in the ADC are McMMAE. Anti-CCL2 (Carlumab)-VcMMAE can induce apoptosis and is utilized in cancer research.
  • Inquiry Price
Inquiry
Size
QTY